11-105044421-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_052889.4(CARD16):​c.245A>G​(p.Tyr82Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

CARD16
NM_052889.4 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.869
Variant links:
Genes affected
CARD16 (HGNC:33701): (caspase recruitment domain family member 16) Enables several functions, including CARD domain binding activity; cysteine-type endopeptidase inhibitor activity; and enzyme binding activity. Involved in several processes, including negative regulation of cysteine-type endopeptidase activity; regulation of gene expression; and regulation of signal transduction. Part of protease inhibitor complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3978818).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CARD16NM_052889.4 linkuse as main transcriptc.245A>G p.Tyr82Cys missense_variant 2/4 ENST00000673097.2 NP_443121.1
CARD16NM_001394580.1 linkuse as main transcriptc.197A>G p.Tyr66Cys missense_variant 2/4 NP_001381509.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CARD16ENST00000673097.2 linkuse as main transcriptc.245A>G p.Tyr82Cys missense_variant 2/4 NM_052889.4 ENSP00000509408 Q5EG05-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 30, 2023The c.245A>G (p.Y82C) alteration is located in exon 2 (coding exon 2) of the CARD16 gene. This alteration results from a A to G substitution at nucleotide position 245, causing the tyrosine (Y) at amino acid position 82 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.049
T;.;.;.
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.76
T;.;T;T
M_CAP
Benign
0.0045
T
MetaRNN
Benign
0.40
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L;L;L;.
MutationTaster
Benign
1.0
N;N;N;N
PROVEAN
Pathogenic
-5.0
D;D;D;D
REVEL
Benign
0.097
Sift
Benign
0.036
D;T;T;T
Sift4G
Uncertain
0.056
T;T;T;.
Polyphen
0.99
D;D;D;.
Vest4
0.23
MutPred
0.40
Gain of catalytic residue at L83 (P = 0.011);Gain of catalytic residue at L83 (P = 0.011);Gain of catalytic residue at L83 (P = 0.011);.;
MVP
0.37
MPC
0.78
ClinPred
0.96
D
GERP RS
0.60
Varity_R
0.23
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-104915148; API